BMJ Open (Oct 2023)

Added value of electrical impedance spectroscopy in adjunction of colposcopy: a prospective cohort study

  • Ilkka Kalliala,
  • Pekka Nieminen,
  • Xavier Carcopino,
  • Charles Redman,
  • Laura Kotaniemi-Talonen,
  • Laura Bergqvist,
  • Annu Heinonen,
  • Karoliina Aro,
  • Mari Kiviharju,
  • Seppo Virtanen,
  • Pirjo-Liisa Omar,
  • Karolina Louvanto

DOI
https://doi.org/10.1136/bmjopen-2023-074921
Journal volume & issue
Vol. 13, no. 10

Abstract

Read online

Objective To assess whether electrical impedance spectroscopy (EIS) as an adjunctive technology enhances the performance of colposcopy.Design Prospective cohort study.Setting University Hospital colposcopy clinic.Participants Colposcopy with EIS for 647 women and conventional colposcopy for 962 women.Interventions Comparison of the performance of colposcopy by referral cervical cytology in two cohorts, with and without EIS as an adjunctive technology.Outcome measures Prevalence of cervical intraepithelial neoplasia grade 2 or worse (CIN2+), diagnostic testing accuracy to detect CIN2+ with and without EIS and their relative differences between cohorts.Results The prevalence of CIN2+ varied between the cohorts according to referral cytology: 17.0% after abnormal squamous cells of unknown significance referral cytology in EIS cohort and 9.1% in the reference cohort, 16.5% and 18.9% after low-grade squamous intraepithelial lesion (LSIL), 44.3% and 58.2% after atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion (HSIL) (atypical squamous cells that cannot exclude HSIL), and 81.9% and 77.0% after HSIL cytology, respectively. Sensitivity to detect CIN2+ was higher in the EIS cohort, varying from 1.79 (95% CI 1.30 to 2.45) after LSIL referral cytology to 1.16 (95% CI 1.09 to 1.23) after HSIL referral cytology, with correspondingly lower specificity after any referral cytology.Conclusions Colposcopy with EIS had overall higher sensitivity but lower specificity to detect CIN2+ than conventional colposcopy. CIN2+ prevalence rates were, however, not consistently higher in the EIS cohort, suggesting innate differences between the cohorts or truly lower detection rates of CIN2+ for EIS, highlighting the need for randomised controlled trials on the effectiveness of EIS.